H-KYLPYWPVLSSL-OH

Ref. 3D-PP44789

Product Information

• Name: H-KYLPYWPVLSSL-OH
• Synonyms: NH2-Lys-Tyr-Leu-Pro-Tyr-Trp-Pro-Val-Leu-Ser-Ser-Leu-OH

Description

Peptide H-KYLPYWPVLSSL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KYLPYWPVLSSL-OH include the following: Structural insights into EphA4 unconventional activation from prediction of the EphA4 and its complex with ribonuclease 1 YC Li , H Yamaguchi , YY Liu, KC Hsu - American Journal of , 2022 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641407/ Discovery and characterization of a novel cyclic peptide that effectively inhibits ephrin binding to the EphA4 receptor and displays anti-angiogenesis activity X Han , Y Xu , Y Yang, J Xi, W Tian, S Duggineni - PloS one, 2013 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0080183 Axonal guidance molecules and the failure of axonal regeneration in the adult mammalian spinal cord S Bolsover, J Fabes - Restorative neurology and , 2008 - content.iospress.comhttps://content.iospress.com/articles/restorative-neurology-and-neuroscience/rnn00448 Regeneration-enhancing effects of EphA4 blocking peptide following corticospinal tract injury in adult rat spinal cord J Fabes, P Anderson, C Brennan - European Journal of , 2007 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1460-9568.2007.05859.x Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation HH Lee , YN Wang , WH Yang , W Xia, Y Wei - Nature , 2021 - nature.comhttps://www.nature.com/articles/s41467-021-23075-2 Peripheral loss of EphA4 ameliorates TBI-induced neuroinflammation and tissue damage EA Kowalski, J Chen , A Hazy, LE Fritsch - Journal of , 2019 - Springerhttps://link.springer.com/article/10.1186/s12974-019-1605-2 HTS by NMR of combinatorial libraries: a fragment-based approach to ligand discovery B Wu, Z Zhang , R Noberini, E Barile, M Giulianotti - Chemistry & biology, 2013 - cell.comhttps://www.cell.com/ccbio/pdf/S1074-5521(12)00416-4.pdf EphA4/Tie2 crosstalk regulates leptomeningeal collateral remodeling following ischemic stroke B Okyere, WA Mills , X Wang, M Chen - The Journal of , 2020 - Am Soc Clin Investighttps://www.jci.org/articles/view/131493 Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of AlzheimerTs disease AKY Fua, KW Hunga, H Huanga, S Gud, Y Shena - PNAS, 2014 - researchgate.nethttps://www.researchgate.net/profile/Shuo-Gu-6/publication/263356772_Blockade_of_EphA4_signaling_ameliorates_hippocampal_synaptic_dysfunctions_in_mouse_models_of_Alzheimer's_disease/links/54a6840c0cf267bdb909396d/Blockade-of-EphA4-signaling-ameliorates-hippocampal-synaptic-dysfunctions-in-mouse-models-of-Alzheimers-disease.pdf Blockade of EphA4 signaling ameliorates hippocampal synaptic dysfunctions in mouse models of Alzheimer's disease AKY Fu, KW Hung, H Huang , S Gu - Proceedings of the , 2014 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1405803111 EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans A Van Hoecke, L Schoonaert , R Lemmens - Nature medicine, 2012 - nature.comhttps://www.nature.com/articles/nm.2901 Eph receptors and ephrins: therapeutic opportunities A Barquilla, EB Pasquale - Annual review of pharmacology and , 2015 - annualreviews.orghttps://www.annualreviews.org/doi/abs/10.1146/annurev-pharmtox-011112-140226

• Brand: Biosynth